Supriya Kumar

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Cross Sectional

Randomized Controlled Trial

Chronic Kidney Disease

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Steven N Fishbane, Juan Jesús Carrero, Supriya Kumar, Eiichiro Kanda, Katarina Hedman, Richard Ofori-Asenso, Naoki Kashihara, Mikhail Naum Kosiborod, Mitja Lainscak, Carol A Pollock, Stenvinkel Peter, David Collins Wheeler, Roberto Pecoits-Filho
Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort. Kidney360 5 (7) (2024)
Steven N Fishbane, Juan Jesús Carrero, Supriya Kumar, Eiichiro Kanda, Katarina Hedman, Richard Ofori-Asenso, Naoki Kashihara, Mikhail Naum Kosiborod, Mitja Lainscak, Carol A Pollock, Stenvinkel Peter, David Collins Wheeler, Roberto Pecoits-Filho
Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort. Kidney360 5 (7) (2024)
Steven N Fishbane, Juan Jesús Carrero, Supriya Kumar, Eiichiro Kanda, Katarina Hedman, Richard Ofori-Asenso, Naoki Kashihara, Mikhail Naum Kosiborod, Mitja Lainscak, Carol A Pollock, Stenvinkel Peter, David Collins Wheeler, Roberto Pecoits-Filho
Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort. Kidney360 5 (7) (2024)
Steven N Fishbane, Juan Jesús Carrero, Supriya Kumar, Eiichiro Kanda, Katarina Hedman, Richard Ofori-Asenso, Naoki Kashihara, Mikhail Naum Kosiborod, Mitja Lainscak, Carol A Pollock, Stenvinkel Peter, David Collins Wheeler, Roberto Pecoits-Filho
Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort. Kidney360 5 (7) (2024)
Supriya Kumar, Matthew Arnold, Glen James, Rema Padman
Developing a common data model approach for DISCOVER CKD: A retrospective, global cohort of real-world patients with chronic kidney disease. PloS one 17 (9) (2022)